Magnet therapy and copper bracelets

1. Introduction

Version followed: static (permanent) magnets and plain copper worn on the body as consumer products (bracelets, wrist straps, necklaces, insoles, mattress pads, bandages), as described by NCCIH, the Arthritis Foundation, sellers' own product pages and US/UK regulators. Pulsed electromagnetic devices and transcranial magnetic stimulation (TMS) are separate, clinician-delivered technologies and are not covered here. The psychotherapist works alongside this method and does not sell, fit, recommend or advise on these products; the guide covers the therapist's own work with clients who use them.

What it is. Magnet therapy places static magnets against or near the skin, usually built into jewellery, straps, insoles, mattress pads or bandages, and is promoted mainly for pain (foot, back, joint), arthritis and fibromyalgia [source: NCCIH Magnets fact sheet; Merck Manual Consumer Version]. Copper bracelets are plain copper bands worn at the wrist, promoted chiefly for arthritis [source: Arthritis Foundation].

Core idea of change, as proponents hold it (attributed, not established).

Magnets: placed on the skin, they are said to act on iron in the blood and so improve circulation and nutrient delivery to joints [source: Arthritis Foundation, describing proponents' claims]. One Japanese seller describes a necklace with alternating north–south magnets that "improves blood circulation in the neck and shoulders" and relieves stiffness [source: Colantotte product page].
Copper: the body is said to lack copper, which the bracelet releases through the skin to reduce joint inflammation; the idea is traced to 19th-century metallotherapy [source: Arthritis Foundation].
"Energy" variants: some wristbands have been sold with explanations of "bio-energy", ionisation, or an "imbalance of positive and negative energy" and "excess static electricity" as the cause of pain [source: FTC v. QT, Inc. (7th Cir. 2008); FTC press release on Media Maverick, 2004]. These are the sellers' concepts and are recorded here as such.

What a client experiences. The client buys a product (pharmacy, health-food shop, online, infomercial, distributor or practitioner) and wears it; there is usually no practitioner session. Some products are sold with money-back guarantees, testimonials and claims that effects wear off or are tied to the first owner [source: FTC v. QT, Inc.].

Who practises it. Mainly manufacturers, retailers and distributors; some complementary practitioners include magnets in their work [uncertain]. There is no recognised professional body or training standard for static magnet therapy [uncertain].

Status in one line each.

Evidence: NCCIH states "Magnets have not been proven to work for any health-related purpose"; a randomised double-blind crossover trial in 70 adults with rheumatoid arthritis found no meaningful effect of magnetic wrist straps or copper bracelets beyond placebo on pain, inflammation or disease activity [source: NCCIH; Richmond et al. 2013].
US: the FTC has acted repeatedly against unsubstantiated health claims (Magnetic Therapeutic Technologies and Pain Stops Here! consent agreements over claims including cancer, announced June 1999 under Operation Cure.All and made final September 1999 [source: FTC 1999 releases]; Media Maverick "balance bracelet", 2004, $400,000 settlement; Q-Ray bracelet, about $16 million plus interest upheld on appeal, 2008) [source: FTC documents].
UK: CAP advice says worn magnets making medicinal claims may be medical devices needing appropriate marking; without it, ads must not make medicinal claims; the ASA has seen no convincing evidence that worn magnets benefit physical or mental health [source: CAP advice, 2020].
Japan: "home-use permanent magnet therapy devices" (kateiyō eikyu jishaku jiki chiryōki) are a designated medical-device category (item 356) in the Health Ministry's standards notification of 2005 (MHLW Notification No. 112), as listed in the PMDA standards database [source: PMDA standards database]; some magnetic necklaces and patches are sold with a certification number and a circulation/stiffness claim [source: Colantotte product page].
Copper bracelets: no regulator action specific to copper is cited here; claims fall under general advertising law [uncertain].

Physical safety as sources state it. Magnets may interfere with medical devices and may not be safe for people with pacemakers or insulin pumps [source: NCCIH]; safety is unclear in pregnancy, with implanted pumps and devices, and with medicines delivered by skin patch [source: Merck Manual]. Many implanted medical devices, including pacemakers and defibrillators, have a "magnet mode" that suspends normal operation and that a strong enough magnet can trigger; in 2021 FDA advised, about high-strength magnets in some phones and smartwatches, keeping them at least six inches from implanted devices, not carrying them in a pocket over the device, and contacting the health care provider with symptoms or questions; it judged the risk low and knew of no related adverse events [source: FDA, Magnets in Cell Phones and Smart Watches, 2021; Cardiovascular Business report]. Minor effects reported in the RA trial: skin irritation (copper bracelet, and possibly nickel buckles on straps), one headache, one metallic taste, dizziness [source: Richmond et al. 2013]. The main risk named by sources is using the products in place of, or to delay, effective care; in suspected rheumatoid arthritis early medical treatment prevents joint damage [source: NCCIH; Arthritis Foundation; University of York release]. MRI: the scanner's field attracts magnetic objects, which can become projectiles, so people and objects are screened before entering, and implanted devices and drug patches must be declared [source: FDA, MRI Benefits and Risks; FDA, What Patients Should Know Before Having an MRI Exam]; declaring worn magnets and metal at screening follows from this [synthesis].

2. Framework

There is no therapeutic protocol for the product itself to describe: it is bought and worn, and sources give no phases [source: NCCIH; sellers' pages]. The framework below is for the psychotherapist's own work and is [synthesis], built on NCCIH's advice that people tell all their health providers about complementary approaches and not use magnets in place of conventional care.

Phase A, recognition (any session; usually 5–15 minutes inside a normal session): routine, non-judgemental inquiry; record what is used, why, source and cost. Move on when use is documented and the client knows it is safe to talk about.
Phase B, meaning and expectations (one session, or woven across several): explore what draws the client, what they hope for, how they explain their symptoms. Move on when you can state the client's explanatory model back to them and they agree with it.
Phase C, safety and coordination (as soon as relevant, before deeper work if a red flag is present): implanted devices, pregnancy, medication patches, delayed diagnosis, children; with consent, liaise with the doctor, cardiology/device clinic or pharmacist. Move on when red flags are either absent or handed to the right professional.
Phase D, informed, values-based decision (one to two sessions, client-paced): support the client's own decision about continuing, stopping or combining with medical care, without pressure either way. Move on when the client has made and owns a decision.
Phase E, ongoing psychological work: chronic pain, health anxiety or somatic symptom work with established approaches (cross-reference Domain II); review at natural points (new symptom, new purchase, new practitioner).
Format: individual, inside ongoing psychotherapy; family sessions when a child or dependent adult is involved. No separate course of sessions is needed in most cases.

3. Guiding principles

[source: NCCIH; APA Ethics Code; otherwise synthesis]

Stay in your lane. You do not perform, sell, fit, prescribe or recommend magnets or copper; in practice, you never answer "should I buy it?" with yes or no, and you route device and medical questions to the doctor (APA Ethics Code).
Curiosity before information. Ask what it means before saying what the evidence is; in practice, the first response to disclosure is a question, not a fact.
Attribute, don't adjudicate. Energy, ionisation and circulation explanations are described as the seller's or client's ideas; in practice, use "the makers say…" and "you've found…", neither "that's real" nor "that's nonsense".
Safety first, harm-weighted. The products are generally low-risk on the skin; the real risks are device interference and delayed care; in practice, always ask about pacemakers, defibrillators, pumps, pregnancy and undiagnosed or worsening symptoms.
Autonomy without abandonment. The client decides; you make sure the decision is informed and keep the medical door open; in practice, no ultimatums and no collusion.
Coordinate with consent. Share information with the doctor or pharmacist only with permission, except where the law or a safeguarding duty requires otherwise (APA Ethics Code).
Validate the suffering, not the claim. Pain, stiffness and fear are real whatever the client attributes improvement to; in practice, reflect the experience separately from the mechanism.
No conflicts of interest. No sales, referrals for gain, testimonials or bartering with products (APA Ethics Code).
Protect the vulnerable. Children, pregnant clients, people with implanted devices, people under financial or group pressure get proactive checks.
Document. What is used, the client's understanding, risk checks, advice to see the doctor, and consent decisions.

4. Intervention inventory

All interventions below are the psychotherapist's own work. None involves handling, fitting, selling or advising on a product. Step-by-step procedures are [synthesis] unless a source is named; source tags show where the content behind a step comes from.

4.1 Routine, non-judgemental inquiry and recording

Purpose / when: at intake, at reviews, and whenever pain, arthritis, sleep, or "natural" approaches come up. NCCIH asks people to tell all their providers about complementary approaches so care can be coordinated safely [source: NCCIH]; clients disclose more when the question is routine.
Steps:
1. Ask as part of a standard list (medicines, supplements, devices, wearables, therapies) so it is not singled out.
2. If yes: what product (bracelet, strap, insole, mattress pad, necklace, patch), magnet, copper or "ionised"/"energy" type, where bought, from whom (shop, online, distributor, practitioner), how much spent, and whether more is being bought.
3. Ask what it is for and whether the doctor knows.
4. Ask the safety screen (see 4.5): pacemaker, defibrillator, insulin or other pump, other implant; pregnancy; medicines via skin patch; children using it.
5. Record in the client's words, without evaluative language; note who else knows.
Example language (illustrative): "I ask everyone about anything they use for their health, including things like supplements, wristbands or magnets. Is there anything like that for you?" / "Thanks for telling me. What made you pick that one?"
Watch for: shame or defensiveness ("I know it's silly, but…") - respond warmly; a quick change of subject; signs of large or escalating spending. Working: the client mentions new products spontaneously at later sessions.

4.2 Exploring meaning, hopes, expectations and explanatory model

Purpose / when: after disclosure, or when the product seems important to the client (identity, family tradition, strong hope, distrust of medicine).
Steps:
1. Ask what they hoped it would do and what it does for them now (pain, sleep, feeling in control, feeling cared for, connection to a parent who wore one).
2. Ask how they understand their symptoms and how the product fits that (circulation, energy, copper deficiency, "natural" vs "chemical").
3. Ask what else they do and what medical care they have had; ask about experiences with doctors (dismissal, side effects, waiting lists).
4. Ask what it would mean if it did not work, or if they stopped.
5. Summarise the explanatory model back and check it.
Example language (illustrative): "When you put the bracelet on, what do you notice, and what does it mean to you?" / "So for you it's partly about doing something yourself rather than relying on tablets - have I got that right?"
Watch for: hope tied to a serious undiagnosed problem; distrust of medicine grounded in real bad experiences (validate those); identity or community investment that makes doubt feel like betrayal; magical-thinking intensity or rigid conviction that may signal a broader presentation (assess in context, not from this alone). Working: the client can name what the product gives them beyond the physical claim.

4.3 Sharing published information on request (neutral information-giving)

Purpose / when: only when the client asks what is known, or when a safety point needs to be made. The aim is accurate, attributed information, not persuasion.
Steps:
1. Ask permission and ask what they already know.
2. Give short, attributed statements: what NCCIH says about evidence; what the 2013 York trial found in rheumatoid arthritis; the safety points about implanted devices [source: NCCIH; Richmond et al. 2013].
3. Offer the source itself rather than your opinion; invite their reaction.
4. Separate the questions: "Is it safe for me?" (doctor/device clinic), "Does it work?" (published evidence), "Is it worth it to me?" (their values).
Example language (illustrative): "Would it help if I told you what the US government's complementary-health centre says, and you can see what you make of it?" / "That's what that trial found; how does that sit with your own experience?"
Watch for: sliding into debate or ridicule; the client feeling judged; overloading with information. Working: the client asks follow-up questions and stays engaged.

4.4 Supporting an informed, values-based decision

Purpose / when: when the client is weighing whether to keep buying or wearing a product, whether to spend more, or whether to delay seeing a doctor.
Steps:
1. Clarify the decision in the client's words.
2. Explore their values (independence, natural approaches, family, money, staying active).
3. List options together, including combining the product with medical care (NCCIH's point that it should not replace conventional care) [source: NCCIH].
4. Weigh costs and benefits as the client sees them, including money and time.
5. Check understanding and pressure: is anyone pushing (seller, distributor, family, group)?
6. Let the client decide; record the decision and any agreed next step (e.g. a GP appointment).
Example language (illustrative): "It's your call. What matters most to you here?" / "Whatever you decide about the bracelet, how would you feel about also getting the joint pain checked?"
Watch for: your own bias steering the client; the client deferring to you to decide; decisions made under sales pressure or guarantees with deadlines. No decision aid specific to magnets or copper is cited here [uncertain]. Working: the client can explain the decision in their own terms and owns it.

4.5 Medical safety screen and coordination with the doctor, device clinic or pharmacist

Purpose / when: whenever magnets are worn and the client has an implanted device, is pregnant, uses medicines by skin patch, or has new, worsening or undiagnosed symptoms.
Steps:
1. Screen: implanted pacemaker or defibrillator, insulin pump or other implanted pump, other implanted electronic device; pregnancy; patch medicines [source: NCCIH; Merck Manual].
2. If any apply, tell the client plainly that sources advise caution and that the decision belongs with the treating clinician; do not give placement or distance advice yourself beyond naming that FDA has advised keeping consumer magnets away from implanted devices and talking to the clinician [source: FDA, Magnets in Cell Phones and Smart Watches, 2021].
3. Ask consent to contact the GP, cardiology or device clinic, or pharmacist; if declined, encourage the client to raise it at their next appointment and record that you did.
4. With consent, send a brief factual note: the product, the client's reasons, and the question for the clinician. No opinion on the product.
5. Encourage declaring worn magnets and metal at any MRI or scan screening [synthesis].
6. Follow up at the next session.
Example language (illustrative): "Because you have a pacemaker, the health information I've seen says magnets near it should be checked with your heart team. Would you be OK with me writing to them, or would you rather ask them yourself?"
Watch for: symptoms such as dizziness, palpitations or fainting in a device user (urgent medical review; [synthesis]); skin irritation from copper or buckles [source: Richmond et al. 2013]; undiagnosed joint pain and swelling (early rheumatology assessment matters [source: University of York release]). Working: the clinician knows, and the client has had a safety answer from the right person.

4.6 Recognising and responding to delay or replacement of medical care

Purpose / when: when the product is used instead of diagnosis or treatment, or the client reduces medicines on the strength of it. Both NCCIH and the Arthritis Foundation identify substitution as the main risk [source: NCCIH; Arthritis Foundation].
Steps:
1. Ask directly whether the client has changed, stopped or put off any treatment or appointment.
2. If yes, explore why (fear of side effects, cost, distrust, belief in the product) without judgement.
3. Do not advise on medicines; route to the prescriber or pharmacist and offer to help the client prepare for that conversation (questions, fears to raise).
4. With consent, inform the doctor; without consent, assess whether the risk to life or serious harm justifies disclosure under your code and law and consult.
5. Record your actions.
Example language (illustrative): "I'm not the right person to say anything about your tablets, but I'd really like you to talk to whoever prescribed them before changing anything. Could we think together about what you'd want to ask them?"
Watch for: concealment from the doctor; claims from sellers that the product replaces medicine (as in the claims the FTC challenged for cancer, HIV, diabetic ulcers and blood pressure [source: FTC analysis of proposed consent order, Magnetic Therapeutic Technologies]). Working: the client re-engages with medical care or makes an informed choice the doctor knows about.

4.7 Recognising financial exploitation, sales and group pressure

Purpose / when: repeated or costly purchases, distributor or "business opportunity" involvement, pressure from a seller, practitioner or group. Regulators have documented features to recognise: testimonials presented as typical results, "test-proven" claims, guarantees with hidden shorter limits, claims that effects wear off after a year or two or work only for the first owner (driving repeat sales), and distributor networks selling through shops and pharmacies [source: FTC v. QT, Inc.; FTC analysis of proposed consent order, Magnetic Therapeutic Technologies].
Steps:
1. Ask about total spending and who benefits from the client's purchases.
2. Ask whether the client sells the products or recruits others, and what that relationship is like (multi-level-marketing dynamics: [synthesis]).
3. Explore pressure: guilt, fear, "you'll lose the benefit", exclusion from a group.
4. Support the client's own budgeting and boundary-setting; signpost consumer advice and refund rights where relevant [synthesis].
5. If a vulnerable adult is being exploited, follow adult safeguarding procedures.
Example language (illustrative): "Roughly how much have these cost you over the past year? How do you feel about that number?" / "What happens in the group if someone says it isn't working for them?"
Watch for: debt, secrecy from family, isolation, cognitive impairment or bereavement increasing vulnerability, high-control group features. Working: the client sets their own spending limit or steps back from sales pressure.

4.8 Children, pregnancy and dependent adults

Purpose / when: a parent or carer uses magnets or copper on a child or dependent adult, or a pregnant client uses magnets.
Steps:
1. Ask what is used, why, and whether the child's doctor knows.
2. Note that safety in pregnancy is unclear [source: Merck Manual]; encourage the client to tell the midwife or obstetrician.
3. For children: the issue for safeguarding is not the bracelet itself but whether needed medical care, diagnosis or treatment is being withheld or delayed [synthesis]. Explore the parent's reasons with respect and encourage medical review.
4. Involve the child at their developmental level: ask what they understand and what they want (assent) [synthesis].
5. If medical neglect is suspected, consult and follow local safeguarding procedures; never name or identify the child outside the proper channels.
Example language (illustrative): "It's clear you're trying everything to help her. What has her doctor said about the pain?"
Watch for: a child with untreated, persistent symptoms; a parent's fear of medicine; small loose magnets around young children (seek medical advice if swallowing is suspected [synthesis]). Working: the child is under appropriate medical care whatever else the family uses.

4.9 Psychological work on pain, health anxiety and somatic symptoms

Purpose / when: most users wear these products for chronic pain, arthritis or vague somatic complaints [source: NCCIH; Arthritis Foundation]. The underlying distress is the therapist's proper focus. Cross-reference Domain II (health anxiety, somatic symptom disorder, chronic pain approaches) for full protocols.
Steps:
1. Assess pain impact, mood, sleep, fear-avoidance, catastrophising and health-anxiety behaviour (checking, reassurance seeking, product-hopping) using established measures you are licensed to use.
2. Offer the client's established psychological options (e.g. CBT for chronic pain, acceptance-based approaches, health-anxiety CBT) per Domain II.
3. Use the client's own observations as data: when did they start wearing it, what happened to symptoms? The York trial lead noted that people often start a device during a flare, so natural easing may be credited to it, and that pain perception is strongly shaped by the mind [source: University of York release]. Explore this gently as a shared curiosity, not a gotcha [synthesis].
4. Build self-efficacy: the client's own actions (pacing, activity, relaxation, sleep) that influence pain.
5. For idiopathic environmental intolerance or fears about "fields" and "energy", use the health-anxiety and somatic-symptom approaches in Domain II.
Example language (illustrative): "Whatever the bracelet is doing, I'm interested in what you've been doing alongside it that might be helping." / "You noticed the pain eased after you started wearing it. What else was going on around then?"
Watch for: reliance on objects as safety behaviours in health anxiety (anxiety rising when the item is removed); product-hopping; invalidation if the client hears "it's all in your mind". Working: the client's functioning improves and attention moves from the product to their own strategies.

4.10 Reporting routes

Purpose / when: misleading health claims, a product causing harm, a seller targeting vulnerable people, or a professional selling to clients.
Steps (by route):
- US advertising and consumer fraud: the Federal Trade Commission, which has taken the actions described in section 1 [source: FTC documents]. Device problems in the US: FDA's MedWatch voluntary reporting, online or on Form FDA 3500 by post or fax [source: FDA, Medical Device Reporting].
- UK advertising: the Advertising Standards Authority, which applies the CAP Code's evidence rules to magnet claims [source: CAP advice].
- UK device safety: the MHRA Yellow Card scheme accepts reports from the public and health professionals on any medical-device safety concern, including unsafe or fake devices; keep the device [source: MHRA Yellow Card medical devices page].
- Other jurisdictions: the national device regulator and advertising or consumer authority [synthesis].
- Professional misconduct (a regulated professional selling or making false claims to patients): the relevant professional or licensing board.
- Children or vulnerable adults at risk: local safeguarding procedures.
1. Discuss with the client and seek consent; most consumer reports can be made by the client.
2. Report only facts; record what was reported and when.
Example language (illustrative): "The claim that it cures your blood pressure isn't something sellers are allowed to make without proof. Would you want to report that ad? I can show you where."
Watch for: breaching confidentiality without a legal basis; making the client feel foolish. Working: the client feels empowered rather than embarrassed.

4.11 Managing your own conflicts of interest and boundaries

Purpose / when: always; especially if you personally use or believe in magnet or copper products, or are offered them as gifts, barter or a business opportunity.
Steps:
1. Never sell, distribute, recommend or refer for gain; decline any distributor role that touches clients [source: APA Ethics Code].
2. Do not solicit testimonials from clients or allow your name to appear in product marketing (APA Ethics Code).
3. Do not accept products as barter if it could be exploitative or contraindicated (APA Ethics Code).
4. Bring personal enthusiasm or scepticism to supervision so it does not steer clients (APA Ethics Code).
5. Practise within competence: device and medical questions go to medical colleagues (APA Ethics Code).
Example language (illustrative): "I don't recommend or sell any health products, so I can stay on your side whatever you decide."
Watch for: pull to share your own view; dual relationships through shared groups or networks. Working: the client experiences you as neutral and safe.

4.12 Documentation and review

Purpose / when: every time the topic comes up.
Steps: record product type, purpose, source, spending, risk screen results, information shared and its source, consent decisions, communications with clinicians, and the client's decision; set a review point [synthesis; APA Ethics Code on documented informed consent].
Example language (illustrative): "I'll make a note that we talked about this and that you're going to ask your heart nurse. Is that fine with you?"
Watch for: judgemental wording in notes; omissions of safety screens. Working: any colleague reading the record would know the risks checked and actions agreed.

5. Handling problems

Sources do not address the psychotherapist's role with these products; all responses below are [synthesis] unless a source is named.

Client feels judged and goes quiet after disclosure. Name it and repair: "I may have sounded like I was questioning you; I'm genuinely interested, not judging." Return to meaning (4.2). Avoid offering evidence until invited.
Client asks "Do you think it works?" Do not give a personal verdict or recommendation. Offer what published sources say, attributed (4.3), then turn to what the client has noticed and values. "I can tell you what research has found, but your experience matters too. What have you noticed?"
Client is certain it works and wants agreement. Validate the relief and the sense of control; stay neutral on mechanism; keep the safety and medical-care questions on the table. Do not argue; arguments harden positions.
Client has an implanted cardiac device or pump and refuses to tell the clinic. Explore the reasons (fear of being told off, embarrassment); offer to help draft what to say; record your advice. If the client develops symptoms suggestive of device problems, advise urgent medical review [synthesis]. Consult a supervisor on whether disclosure without consent is justified [source: APA Ethics Code].
Client has stopped or delayed medical treatment. Do not advise on medicines. Explore fears; support a conversation with the prescriber; with consent inform the doctor; escalate per risk (4.6). The Arthritis Foundation and NCCIH both identify replacement of effective care as the main danger [source: Arthritis Foundation; NCCIH].
Rupture over the therapist's perceived scepticism. Acknowledge, take responsibility for your part, reaffirm that the client decides. Check whether past medical dismissal is being re-enacted in the room.
Rupture over the therapist's perceived endorsement. If a client later says "you said it was fine", clarify that you don't recommend products and that safety questions belong with the doctor; review your notes and practice.
Repeated purchases, debt or distributor involvement. Use 4.7; explore whether shame keeps the client buying ("if I stop, I've wasted all that"); work on sunk-cost thinking with compassion; signpost debt and consumer advice; consider adult safeguarding if exploitation of a vulnerable adult is suspected.
Family conflict (one member mocks, another believes). Hold neutral space; focus on shared goals (the person's comfort, function, safety); help family members ask questions rather than lecture.
Health-anxious client cannot remove the item. Treat as a possible safety behaviour within health-anxiety work (Domain II): graded, collaborative experiments only with the client's consent, never imposed, and never framed as a test of the product's claims.
Non-adherence to agreed medical follow-up. Explore barriers (access, cost, fear, past experience); problem-solve practically; revisit values from 4.4.
Client experiences skin irritation, metallic taste or dizziness. These were reported in the York trial with copper and magnetic devices [source: Richmond et al. 2013]; advise speaking to a pharmacist or GP; you do not advise on continuing or stopping the product.
Client wants you to write a testimonial, endorse, or try the product. Decline politely, explaining your role [source: APA Ethics Code].
Seller or practitioner claims the product treats cancer, HIV, diabetes or blood pressure. Such claims were challenged by the FTC as unsubstantiated [source: FTC analysis of proposed consent order, Magnetic Therapeutic Technologies]. Treat as a risk flag for substitution of care (4.6) and consider reporting routes (4.10).
Overwhelm in a client with multiple chronic conditions and many products. Slow down; prioritise safety first (implanted devices, missed treatment), then meaning; avoid an "audit" feel.
Therapist's own discomfort or belief. Take it to supervision; review conflicts of interest (4.11).

Sources

← Previous · XII-082NES Health body-field scanning Next · XII-084 →Consumer PEMF devices (BEMER)